Anthropic is preparing for a possible Nasdaq debut as soon as mid-November while offering investors a second, more unusual proposition: a growing slice of its equity, the company says, will be set aside for public-benefit work. The immediate financial backdrop is formidable. The Wall Street Journal, CNBC and the BBC reported that Anthropic told investors its third-quarter 2026 revenue reached about $16.8bn, up roughly 45% from the prior quarter.

Those reports put second-quarter revenue at about $11.5bn to $11.6bn and first-quarter revenue at roughly $4.7bn. The figures were reported from investor briefings rather than a public, audited filing. The company had confidentially submitted a draft S-1 registration statement to the US Securities and Exchange Commission on June 1.

Anthropic said then that neither the number of shares nor the price had been set. There was still no public prospectus, ticker or price range as of October 19. Bloomberg and Reuters have reported that formal IPO marketing could begin in the week of November 9, with trading potentially starting before the November 26 Thanksgiving holiday.

Bloomberg reported that Nasdaq was the intended venue and that Morgan Stanley and Goldman Sachs were leading the deal, alongside JPMorgan. Anthropic and the banks have not publicly confirmed those details. The timetable follows reports of increasingly ambitious — and increasingly contested — valuation expectations.

Anthropic’s May Series H financing was priced at a $965bn post-money valuation, according to the company. Reuters reported this month that the company was seeking a valuation above $2tn; Bloomberg said some prospective investors had discussed a $1.8tn-to-$2tn range. Other attendees at the company’s October 14 investor day, cited anonymously in press reports, were said to have tempered expectations nearer $1.5tn as revenue growth slowed from its earlier pace.

A fund, not a single 20% transfer The announcement on October 18 does not mean Anthropic is putting a flat 20% stake into one charitable vehicle. Subject to shareholder approval, the company says it will commit 5% of its shares to a newly created Anthropic Public Benefit Fund LLC. Its board may add another 2% for every 50% increase in the company’s value above an undisclosed baseline.

“When combined with today’s announcement, roughly 20% of Anthropic shares will be dedicated to the public good,” Anthropic said in its October 18 announcement. That larger figure combines the proposed fund stake with the co-founders’ earlier pledge to donate 80% of their own equity and an employee equity-donation matching programme, in which Anthropic says about half its employees participate. The ultimate percentage could rise further if the valuation triggers are met.

The structure matters. The fund will be a wholly owned limited-liability company, not a 501(c)(3) charity. Anthropic says that choice gives it latitude to make conventional grants, direct distributions to particular populations and interventions connected to AI-driven labour disruption.

It has already committed $200m, by its account, to research and programmes addressing AI’s labour-market effects. The company also said fund-held equity would not be used for lobbying or political giving in the US or abroad. Lise Buyer, a partner at IPO advisory firm Class V Group, told CNBC that establishing the mechanism was necessary IPO preparation but also beneficial to Anthropic’s image as AI reshapes employment.

The timing makes the distinction between stated mission and market presentation difficult to avoid: the fund arrives just as Anthropic needs public investors to assign a durable value to growth that remains expensive to produce.

Public-benefit claims meet public-market controls

Anthropic is already a Delaware public-benefit corporation, and the new fund sits beside — rather than replaces — its Long-Term Benefit Trust. The trust is a separate governance body designed to hold the company to its stated purpose of developing advanced AI for humanity’s long-term benefit. Anthropic said in July that former Federal Reserve chair Ben Bernanke had joined trustees including Richard Fontaine, Neil Buddy Shah and Mariano-Florentino Cuéllar.

Reporting on Anthropic’s confidential prospectus has described another layer of control: a Founder LLC holding a Class F share with 50.1% voting power on key matters, while the Long-Term Benefit Trust elects four of seven directors. Those provisions could limit the influence of ordinary Class A shareholders and may still change before a public filing. That architecture differs from OpenAI’s.

OpenAI has said its foundation holds 26% of its operating group and a valuation-linked warrant, while controlling the group’s board. Anthropic’s fund is principally an economic and philanthropic vehicle within a broader system of founder voting rights and trust oversight; its advertised 20% public-good commitment is not equivalent to a foundation owning 20% of the company. Investors will be weighing those governance constraints against unusually fast commercial expansion and unusually large costs.